Drug industry steps up for credentialing group

Share this article:
The National Commission for the Certification of CME Professionals' voluntary certification program will not be out until fall 2007. That has not kept AstraZeneca and Merck, as well as several medical education entities from becoming “charter donors.” To earn the credential, candidates will have to meet specific criteria based on evidence of professional performance,
experience and completion of self-assessment, according to information on NC-CME.org.

Judy Ribble, PhD, NC-CME president, said she hopes small donations help the group attract a large foundation grant.

Maureen Doyle-Scharff, director of professional alliances, Ross, said, credentialing “would be a very positive step in the right direction from an industry perspective,” as a way to help ensure proposal competency.

Some medical societies agree, as their CME staffs need an increasingly broad skill set to collaborate on maintenance of certification.

Not everyone fully endorses NC-CME, and questions linger, such as who will pay for the
credential and test questions, who should take the exam and what's an apt re-certification plan.

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.